retatrutide ozempic vs An Experimental Weight Loss Drug

Nausea typically occurs during the first 4-8 weeks of treatment or following dose increases, with many patients experiencing gradual improvement as their body adjusts to the medication

This tag-team approach also means patients may experience more substantial weight loss results compared to medications that only target GLP-1 receptors

This is because the medicine is still being tested

And that comes with some risks

Even if your schedule rotates, most shift workers have one day per week that is relatively predictable

These realities show that while GLP-1s help reduce weight, they rarely address the underlying metabolic factors that drive long-term weight gain